AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 101 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,813 | -22.9% | 7,024 | +34.0% | 0.00% | 0.0% |
| Q2 2023 | $58,134 | -27.8% | 5,242 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $80,465 | -15.0% | 5,242 | +22.4% | 0.00% | -25.0% |
| Q4 2022 | $94,696 | +60.5% | 4,281 | +16.7% | 0.00% | +33.3% |
| Q3 2022 | $59,000 | +11.3% | 3,667 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $53,000 | 0.0% | 3,667 | +27.0% | 0.00% | 0.0% |
| Q1 2022 | $53,000 | -23.2% | 2,887 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $69,000 | -2.8% | 2,887 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $71,000 | +16.4% | 2,887 | +16.4% | 0.00% | +50.0% |
| Q2 2021 | $61,000 | +13.0% | 2,480 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $54,000 | +50.0% | 2,480 | +74.0% | 0.00% | 0.0% |
| Q4 2020 | $36,000 | -10.0% | 1,425 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $40,000 | – | 1,425 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
| COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
| Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
| 5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
| RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
| RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
| COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
| Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
| Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
| Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |